カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

副甲状腺疾患治療のグローバル市場2023：カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他

■ 英語タイトル：Global Treatment of Parathyroid Disease Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11601）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11601
■ 発行日：2023年8月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[副甲状腺疾患治療のグローバル市場2023：カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、副甲状腺疾患治療のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の副甲状腺疾患治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 副甲状腺疾患治療の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

副甲状腺疾患治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他

用途別セグメント
・病院、診療所、その他

主要な市場プレーヤー
・CTTQ、Roche、Future Health Pharma、KPC Pharmaceuticals、Teva Pharmaceutical、Nantong Huashan Pharmaceutical、Teijin Pharma、Kyowa Kirin、Cheplapharm Arzneimittel、Jiangsu Hengrui Pharmaceuticals、Novartis、Chongqing Yaoyou Pharmaceutical、AbbVie、Hebei Renhe Yikang Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、副甲状腺疾患治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な副甲状腺疾患治療メーカーの企業概要、2019年～2022年までの副甲状腺疾患治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な副甲状腺疾患治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別副甲状腺疾患治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの副甲状腺疾患治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での副甲状腺疾患治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および副甲状腺疾患治療の産業チェーンを掲載しています。
・第14、15章では、副甲状腺疾患治療の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 副甲状腺疾患治療の概要
– 種類別分析（2018年vs2022年vs2029年）：カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界の副甲状腺疾患治療市場規模・予測
– 世界の副甲状腺疾患治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– CTTQ、Roche、Future Health Pharma、KPC Pharmaceuticals、Teva Pharmaceutical、Nantong Huashan Pharmaceutical、Teijin Pharma、Kyowa Kirin、Cheplapharm Arzneimittel、Jiangsu Hengrui Pharmaceuticals、Novartis、Chongqing Yaoyou Pharmaceutical、AbbVie、Hebei Renhe Yikang Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他
・用途別分析2018年-2029年：病院、診療所、その他
・副甲状腺疾患治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・副甲状腺疾患治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・副甲状腺疾患治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・副甲状腺疾患治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・副甲状腺疾患治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Treatment of Parathyroid Disease
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Treatment of Parathyroid Disease Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Calcitriol
1.3.3 Alfacalcidol
1.3.4 Salmon Calcitonin
1.3.5 Paricalcitol
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Treatment of Parathyroid Disease Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Treatment of Parathyroid Disease Market Size & Forecast
1.5.1 Global Treatment of Parathyroid Disease Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Treatment of Parathyroid Disease Sales Quantity (2018-2029)
1.5.3 Global Treatment of Parathyroid Disease Average Price (2018-2029)
2 Manufacturers Profiles
2.1 CTTQ
2.1.1 CTTQ Details
2.1.2 CTTQ Major Business
2.1.3 CTTQ Treatment of Parathyroid Disease Product and Services
2.1.4 CTTQ Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CTTQ Recent Developments/Updates
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Treatment of Parathyroid Disease Product and Services
2.2.4 Roche Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments/Updates
2.3 Future Health Pharma
2.3.1 Future Health Pharma Details
2.3.2 Future Health Pharma Major Business
2.3.3 Future Health Pharma Treatment of Parathyroid Disease Product and Services
2.3.4 Future Health Pharma Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Future Health Pharma Recent Developments/Updates
2.4 KPC Pharmaceuticals
2.4.1 KPC Pharmaceuticals Details
2.4.2 KPC Pharmaceuticals Major Business
2.4.3 KPC Pharmaceuticals Treatment of Parathyroid Disease Product and Services
2.4.4 KPC Pharmaceuticals Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 KPC Pharmaceuticals Recent Developments/Updates
2.5 Teva Pharmaceutical
2.5.1 Teva Pharmaceutical Details
2.5.2 Teva Pharmaceutical Major Business
2.5.3 Teva Pharmaceutical Treatment of Parathyroid Disease Product and Services
2.5.4 Teva Pharmaceutical Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teva Pharmaceutical Recent Developments/Updates
2.6 Nantong Huashan Pharmaceutical
2.6.1 Nantong Huashan Pharmaceutical Details
2.6.2 Nantong Huashan Pharmaceutical Major Business
2.6.3 Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Product and Services
2.6.4 Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Nantong Huashan Pharmaceutical Recent Developments/Updates
2.7 Teijin Pharma
2.7.1 Teijin Pharma Details
2.7.2 Teijin Pharma Major Business
2.7.3 Teijin Pharma Treatment of Parathyroid Disease Product and Services
2.7.4 Teijin Pharma Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Teijin Pharma Recent Developments/Updates
2.8 Kyowa Kirin
2.8.1 Kyowa Kirin Details
2.8.2 Kyowa Kirin Major Business
2.8.3 Kyowa Kirin Treatment of Parathyroid Disease Product and Services
2.8.4 Kyowa Kirin Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Kyowa Kirin Recent Developments/Updates
2.9 Cheplapharm Arzneimittel
2.9.1 Cheplapharm Arzneimittel Details
2.9.2 Cheplapharm Arzneimittel Major Business
2.9.3 Cheplapharm Arzneimittel Treatment of Parathyroid Disease Product and Services
2.9.4 Cheplapharm Arzneimittel Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cheplapharm Arzneimittel Recent Developments/Updates
2.10 Jiangsu Hengrui Pharmaceuticals
2.10.1 Jiangsu Hengrui Pharmaceuticals Details
2.10.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.10.3 Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Product and Services
2.10.4 Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Treatment of Parathyroid Disease Product and Services
2.11.4 Novartis Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Novartis Recent Developments/Updates
2.12 Chongqing Yaoyou Pharmaceutical
2.12.1 Chongqing Yaoyou Pharmaceutical Details
2.12.2 Chongqing Yaoyou Pharmaceutical Major Business
2.12.3 Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Product and Services
2.12.4 Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
2.13 AbbVie
2.13.1 AbbVie Details
2.13.2 AbbVie Major Business
2.13.3 AbbVie Treatment of Parathyroid Disease Product and Services
2.13.4 AbbVie Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 AbbVie Recent Developments/Updates
2.14 Hebei Renhe Yikang Pharmaceutical
2.14.1 Hebei Renhe Yikang Pharmaceutical Details
2.14.2 Hebei Renhe Yikang Pharmaceutical Major Business
2.14.3 Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Product and Services
2.14.4 Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hebei Renhe Yikang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Treatment of Parathyroid Disease by Manufacturer
3.1 Global Treatment of Parathyroid Disease Sales Quantity by Manufacturer (2018-2023)
3.2 Global Treatment of Parathyroid Disease Revenue by Manufacturer (2018-2023)
3.3 Global Treatment of Parathyroid Disease Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Treatment of Parathyroid Disease by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Treatment of Parathyroid Disease Manufacturer Market Share in 2022
3.4.2 Top 6 Treatment of Parathyroid Disease Manufacturer Market Share in 2022
3.5 Treatment of Parathyroid Disease Market: Overall Company Footprint Analysis
3.5.1 Treatment of Parathyroid Disease Market: Region Footprint
3.5.2 Treatment of Parathyroid Disease Market: Company Product Type Footprint
3.5.3 Treatment of Parathyroid Disease Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Treatment of Parathyroid Disease Market Size by Region
4.1.1 Global Treatment of Parathyroid Disease Sales Quantity by Region (2018-2029)
4.1.2 Global Treatment of Parathyroid Disease Consumption Value by Region (2018-2029)
4.1.3 Global Treatment of Parathyroid Disease Average Price by Region (2018-2029)
4.2 North America Treatment of Parathyroid Disease Consumption Value (2018-2029)
4.3 Europe Treatment of Parathyroid Disease Consumption Value (2018-2029)
4.4 Asia-Pacific Treatment of Parathyroid Disease Consumption Value (2018-2029)
4.5 South America Treatment of Parathyroid Disease Consumption Value (2018-2029)
4.6 Middle East and Africa Treatment of Parathyroid Disease Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Treatment of Parathyroid Disease Sales Quantity by Type (2018-2029)
5.2 Global Treatment of Parathyroid Disease Consumption Value by Type (2018-2029)
5.3 Global Treatment of Parathyroid Disease Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Treatment of Parathyroid Disease Sales Quantity by Application (2018-2029)
6.2 Global Treatment of Parathyroid Disease Consumption Value by Application (2018-2029)
6.3 Global Treatment of Parathyroid Disease Average Price by Application (2018-2029)
7 North America
7.1 North America Treatment of Parathyroid Disease Sales Quantity by Type (2018-2029)
7.2 North America Treatment of Parathyroid Disease Sales Quantity by Application (2018-2029)
7.3 North America Treatment of Parathyroid Disease Market Size by Country
7.3.1 North America Treatment of Parathyroid Disease Sales Quantity by Country (2018-2029)
7.3.2 North America Treatment of Parathyroid Disease Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Treatment of Parathyroid Disease Sales Quantity by Type (2018-2029)
8.2 Europe Treatment of Parathyroid Disease Sales Quantity by Application (2018-2029)
8.3 Europe Treatment of Parathyroid Disease Market Size by Country
8.3.1 Europe Treatment of Parathyroid Disease Sales Quantity by Country (2018-2029)
8.3.2 Europe Treatment of Parathyroid Disease Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Treatment of Parathyroid Disease Market Size by Region
9.3.1 Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Treatment of Parathyroid Disease Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Treatment of Parathyroid Disease Sales Quantity by Type (2018-2029)
10.2 South America Treatment of Parathyroid Disease Sales Quantity by Application (2018-2029)
10.3 South America Treatment of Parathyroid Disease Market Size by Country
10.3.1 South America Treatment of Parathyroid Disease Sales Quantity by Country (2018-2029)
10.3.2 South America Treatment of Parathyroid Disease Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Treatment of Parathyroid Disease Market Size by Country
11.3.1 Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Treatment of Parathyroid Disease Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Treatment of Parathyroid Disease Market Drivers
12.2 Treatment of Parathyroid Disease Market Restraints
12.3 Treatment of Parathyroid Disease Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Treatment of Parathyroid Disease and Key Manufacturers
13.2 Manufacturing Costs Percentage of Treatment of Parathyroid Disease
13.3 Treatment of Parathyroid Disease Production Process
13.4 Treatment of Parathyroid Disease Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Treatment of Parathyroid Disease Typical Distributors
14.3 Treatment of Parathyroid Disease Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Treatment of Parathyroid Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Treatment of Parathyroid Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CTTQ Basic Information, Manufacturing Base and Competitors
Table 4. CTTQ Major Business
Table 5. CTTQ Treatment of Parathyroid Disease Product and Services
Table 6. CTTQ Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CTTQ Recent Developments/Updates
Table 8. Roche Basic Information, Manufacturing Base and Competitors
Table 9. Roche Major Business
Table 10. Roche Treatment of Parathyroid Disease Product and Services
Table 11. Roche Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Roche Recent Developments/Updates
Table 13. Future Health Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Future Health Pharma Major Business
Table 15. Future Health Pharma Treatment of Parathyroid Disease Product and Services
Table 16. Future Health Pharma Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Future Health Pharma Recent Developments/Updates
Table 18. KPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. KPC Pharmaceuticals Major Business
Table 20. KPC Pharmaceuticals Treatment of Parathyroid Disease Product and Services
Table 21. KPC Pharmaceuticals Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. KPC Pharmaceuticals Recent Developments/Updates
Table 23. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Major Business
Table 25. Teva Pharmaceutical Treatment of Parathyroid Disease Product and Services
Table 26. Teva Pharmaceutical Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Teva Pharmaceutical Recent Developments/Updates
Table 28. Nantong Huashan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Nantong Huashan Pharmaceutical Major Business
Table 30. Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Product and Services
Table 31. Nantong Huashan Pharmaceutical Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Nantong Huashan Pharmaceutical Recent Developments/Updates
Table 33. Teijin Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Teijin Pharma Major Business
Table 35. Teijin Pharma Treatment of Parathyroid Disease Product and Services
Table 36. Teijin Pharma Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Teijin Pharma Recent Developments/Updates
Table 38. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 39. Kyowa Kirin Major Business
Table 40. Kyowa Kirin Treatment of Parathyroid Disease Product and Services
Table 41. Kyowa Kirin Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Kyowa Kirin Recent Developments/Updates
Table 43. Cheplapharm Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 44. Cheplapharm Arzneimittel Major Business
Table 45. Cheplapharm Arzneimittel Treatment of Parathyroid Disease Product and Services
Table 46. Cheplapharm Arzneimittel Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cheplapharm Arzneimittel Recent Developments/Updates
Table 48. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Jiangsu Hengrui Pharmaceuticals Major Business
Table 50. Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Product and Services
Table 51. Jiangsu Hengrui Pharmaceuticals Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 53. Novartis Basic Information, Manufacturing Base and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Treatment of Parathyroid Disease Product and Services
Table 56. Novartis Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Novartis Recent Developments/Updates
Table 58. Chongqing Yaoyou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Chongqing Yaoyou Pharmaceutical Major Business
Table 60. Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Product and Services
Table 61. Chongqing Yaoyou Pharmaceutical Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
Table 63. AbbVie Basic Information, Manufacturing Base and Competitors
Table 64. AbbVie Major Business
Table 65. AbbVie Treatment of Parathyroid Disease Product and Services
Table 66. AbbVie Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. AbbVie Recent Developments/Updates
Table 68. Hebei Renhe Yikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Hebei Renhe Yikang Pharmaceutical Major Business
Table 70. Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Product and Services
Table 71. Hebei Renhe Yikang Pharmaceutical Treatment of Parathyroid Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Hebei Renhe Yikang Pharmaceutical Recent Developments/Updates
Table 73. Global Treatment of Parathyroid Disease Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Treatment of Parathyroid Disease Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Treatment of Parathyroid Disease Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Treatment of Parathyroid Disease, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Treatment of Parathyroid Disease Production Site of Key Manufacturer
Table 78. Treatment of Parathyroid Disease Market: Company Product Type Footprint
Table 79. Treatment of Parathyroid Disease Market: Company Product Application Footprint
Table 80. Treatment of Parathyroid Disease New Market Entrants and Barriers to Market Entry
Table 81. Treatment of Parathyroid Disease Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Treatment of Parathyroid Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Treatment of Parathyroid Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Treatment of Parathyroid Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Treatment of Parathyroid Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Treatment of Parathyroid Disease Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Treatment of Parathyroid Disease Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Treatment of Parathyroid Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Treatment of Parathyroid Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Treatment of Parathyroid Disease Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Treatment of Parathyroid Disease Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Treatment of Parathyroid Disease Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Treatment of Parathyroid Disease Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Treatment of Parathyroid Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Treatment of Parathyroid Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Treatment of Parathyroid Disease Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Treatment of Parathyroid Disease Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Treatment of Parathyroid Disease Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Treatment of Parathyroid Disease Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Treatment of Parathyroid Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Treatment of Parathyroid Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Treatment of Parathyroid Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Treatment of Parathyroid Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Treatment of Parathyroid Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Treatment of Parathyroid Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Treatment of Parathyroid Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Treatment of Parathyroid Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Treatment of Parathyroid Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Treatment of Parathyroid Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Treatment of Parathyroid Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Treatment of Parathyroid Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Treatment of Parathyroid Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Treatment of Parathyroid Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Treatment of Parathyroid Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Treatment of Parathyroid Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Treatment of Parathyroid Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Treatment of Parathyroid Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Treatment of Parathyroid Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Treatment of Parathyroid Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Treatment of Parathyroid Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Treatment of Parathyroid Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Treatment of Parathyroid Disease Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Treatment of Parathyroid Disease Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Treatment of Parathyroid Disease Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Treatment of Parathyroid Disease Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Treatment of Parathyroid Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Treatment of Parathyroid Disease Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Treatment of Parathyroid Disease Raw Material
Table 141. Key Manufacturers of Treatment of Parathyroid Disease Raw Materials
Table 142. Treatment of Parathyroid Disease Typical Distributors
Table 143. Treatment of Parathyroid Disease Typical Customers
List of Figures
Figure 1. Treatment of Parathyroid Disease Picture
Figure 2. Global Treatment of Parathyroid Disease Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Treatment of Parathyroid Disease Consumption Value Market Share by Type in 2022
Figure 4. Calcitriol Examples
Figure 5. Alfacalcidol Examples
Figure 6. Salmon Calcitonin Examples
Figure 7. Paricalcitol Examples
Figure 8. Other Examples
Figure 9. Global Treatment of Parathyroid Disease Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Treatment of Parathyroid Disease Consumption Value Market Share by Application in 2022
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Other Examples
Figure 14. Global Treatment of Parathyroid Disease Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Treatment of Parathyroid Disease Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Treatment of Parathyroid Disease Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Treatment of Parathyroid Disease Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Treatment of Parathyroid Disease Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Treatment of Parathyroid Disease Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Treatment of Parathyroid Disease by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Treatment of Parathyroid Disease Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Treatment of Parathyroid Disease Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Treatment of Parathyroid Disease Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Treatment of Parathyroid Disease Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Treatment of Parathyroid Disease Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Treatment of Parathyroid Disease Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Treatment of Parathyroid Disease Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Treatment of Parathyroid Disease Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Treatment of Parathyroid Disease Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Treatment of Parathyroid Disease Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Treatment of Parathyroid Disease Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Treatment of Parathyroid Disease Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Treatment of Parathyroid Disease Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Treatment of Parathyroid Disease Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Treatment of Parathyroid Disease Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Treatment of Parathyroid Disease Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Treatment of Parathyroid Disease Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Treatment of Parathyroid Disease Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Treatment of Parathyroid Disease Consumption Value Market Share by Region (2018-2029)
Figure 56. China Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Treatment of Parathyroid Disease Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Treatment of Parathyroid Disease Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Treatment of Parathyroid Disease Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Treatment of Parathyroid Disease Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Treatment of Parathyroid Disease Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Treatment of Parathyroid Disease Market Drivers
Figure 77. Treatment of Parathyroid Disease Market Restraints
Figure 78. Treatment of Parathyroid Disease Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Treatment of Parathyroid Disease in 2022
Figure 81. Manufacturing Process Analysis of Treatment of Parathyroid Disease
Figure 82. Treatment of Parathyroid Disease Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 副甲状腺＆関連医薬品のグローバル市場2023：カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他
  • パジェット病治療のグローバル市場（2022年-2029年）：ビスフォスフォネート、カルシトニン類似体（サケカルシトニン）、鎮痛薬、カルシウム、ビタミンDサプリメント
  • ハンチントン病治療のグローバル市場2023：テトラベナジン、選択的セロトニン再取り込み阻害剤、クロルプロマジン、ハロペリドール、リスペリドン、オランザピン、クロザピン、その他
  • 世界のロザイ・ドルフマン病治療市場2023年：企業・地域・タイプ・用途別分析
  • ウィルソン病用診断のグローバル市場2023：ペニシラミン、トリエンチン、テトラチオモリブデン酸
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11601 )"副甲状腺疾患治療のグローバル市場2023：カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他" (英文：Global Treatment of Parathyroid Disease Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。